Aeglea BioTherapeutics In... (AGLE)
NASDAQ: AGLE
· Real-Time Price · USD
12.01
0.75 (6.66%)
At close: Nov 27, 2023, 10:00 PM
Aeglea BioTherapeutics Revenue
Aeglea BioTherapeutics reported an annual revenue of $0, reflecting a 0% growth. For the quarter ending March 31, 2025, Aeglea BioTherapeutics generated $0 in revenue.
Revenue (ttm)
0
Revenue Growth
n/a
Price / Sales Ratio
0
Revenue / Employee
0
Employees
69
Market Cap
48.63M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | % Change |
|---|---|---|
| Dec 31, 2024 | 0 | -100.00% |
| Dec 31, 2022 | 2.33M | -87.57% |
| Dec 31, 2021 | 18.74M | +Infinity% |
| Dec 31, 2020 | 0 | n/a |
| Dec 31, 2019 | 0 | -100.00% |
| Dec 31, 2018 | 3.89M | -25.30% |
| Dec 31, 2017 | 5.21M | +12.47% |
| Dec 31, 2016 | 4.63M | -23.94% |
| Dec 31, 2015 | 6.08M | +Infinity% |
| Dec 31, 2014 | 0 | n/a |